科美诊断：2025年年度业绩预告

Group 1 - The company, Kemei Diagnostics, announced an expected net profit attributable to shareholders for the year 2025 to be between RMB 40 million and RMB 48 million, representing a year-on-year decrease of 62.23% to 68.52% [2] - The expected net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between RMB 26 million and RMB 32 million, reflecting a year-on-year decline of 68.23% to 74.19% [2]